KYMPOINT Trademark

Trademark Overview


On Monday, March 27, 2017, a trademark application was filed for KYMPOINT with the United States Patent and Trademark Office. The USPTO has given the KYMPOINT trademark a serial number of 79209834. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, June 28, 2024. This trademark is owned by Novartis AG. The KYMPOINT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system, and the genitourinary system, and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infective, antiviral and antibiotic preparations
kympoint

General Information


Serial Number79209834
Word MarkKYMPOINT
Filing DateMonday, March 27, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, June 28, 2024
Registration Number5352768
Registration DateTuesday, December 12, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 26, 2017

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system, and the genitourinary system, and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infective, antiviral and antibiotic preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 28, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Friday, June 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 15, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, August 14, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 17, 2017ASSIGNED TO EXAMINER
Tuesday, June 20, 2017APPLICATION FILING RECEIPT MAILED
Thursday, June 22, 2017NON-FINAL ACTION WRITTEN
Friday, June 23, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, July 1, 2017REFUSAL PROCESSED BY MPU
Saturday, July 1, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 21, 2017REFUSAL PROCESSED BY IB
Wednesday, September 6, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 26, 2017PUBLISHED FOR OPPOSITION
Tuesday, September 26, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 12, 2017REGISTERED-PRINCIPAL REGISTER
Monday, March 12, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, March 26, 2018FINAL DISPOSITION NOTICE SENT TO IB
Saturday, May 12, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 12, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, June 28, 2024CANCELLED SECTION 71
Monday, March 26, 2018FINAL DISPOSITION PROCESSED
Monday, August 14, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 15, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER